Report of Disclosure Revision
Revision Date 2022-05-20
1. Disclosure Documents in relation with Revision Decision on Acquisition of Tangible Assets
2. Submission date of documents 2022-04-29
3. Reason for Revision Extension of preferential negotiation period related to land sales contract
4. Revised Information
information before revision after revision
7. Other matters to be
factored into investment
decisions
- The above '5. Scheduled
Acquisition Date' is
after the purchase price
is paid in full, and the
land sale contract is
scheduled to be concluded
in May 2022.
- The above '5. Scheduled
Acquisition Date'is
after the purchase price
is paid in full, and as
the preferential
negotiation period
related to the land sales
contract is extended, a
disclosure of correction
will be made at the time
the contract is concluded.
-
Decision on Acquisition of Tangible Assets
1. Type of asset to be acquired Land & buildings
- Name of asset to be acquired Songdo International City High-tech Industrial Cluster (C) Ki19
(430 Songdo-dong, Yeonsu-gu, Incheon)
2. Details of acquisition Acquisition price (KRW) 426,022,798,554
Total assets (KRW) 7,970,010,786,863
Ratio to total assets (%) 5.35
Classified as a large-sized corporation? Yes
3. Counterparty Incheon Free Economic Zone Authority (IFEZ)
4. Purpose of acquisition 2nd BIO Campus site purchase
5. Scheduled acquisition date 2025-04-30
6. Date of board resolution (decision date) 2022-03-29
- Attendance of outside directors Present (No.) 4
Absent (No.) -
- Attendance of auditors (members of Audit Committee who are not outside directors) -
7. Other matters to be factored into investment decisions
- The above case is for the purchase of a site for the 2nd Bio Campus, and we have
been selected as the preferred bidder and are in the process of negotiating
to conclude a land sale contract.

- The above total assets under 'Details of acquisition' are based on the
consolidated financial statements as of the end of 2021.

- The above '5. Scheduled Acquisition Date'is after the purchase price is paid in
full, and as the preferential negotiation period related to the land sales
contract is extended, a disclosure of correction will be made at the time
the contract is concluded.

- Details such as acquisition amount and scheduled acquisition date are subject
to change later.
※ Related disclosure -

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Samsung Biologics Co. Ltd. published this content on 23 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 May 2022 07:35:07 UTC.